Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 364

1.

Damage threshold in adult rabbit eyes after scleral cross-linking by riboflavin/blue light application.

Iseli HP, Körber N, Karl A, Koch C, Schuldt C, Penk A, Liu Q, Huster D, Käs J, Reichenbach A, Wiedemann P, Francke M.

Exp Eye Res. 2015 Jul 21. pii: S0014-4835(15)00224-9. doi: 10.1016/j.exer.2015.07.005. [Epub ahead of print]

PMID:
26208440
2.

Efficacy of Blue-Light Cross-linking on Human Scleral Reinforcement.

Zhang M, Zou Y, Zhang F, Zhang X, Wang M.

Optom Vis Sci. 2015 Aug;92(8):873-8. doi: 10.1097/OPX.0000000000000642.

PMID:
26099056
3.

Minocycline-induced hyperpigmentation of tympanic membrane, sclera, teeth, and pinna.

Reese S, Grundfast K.

Laryngoscope. 2015 Jun 8. doi: 10.1002/lary.25365. [Epub ahead of print]

PMID:
26059453
4.

Keratoglobus: An experience at a tertiary eye care center in India.

Rathi VM, Murthy SI, Bagga B, Taneja M, Chaurasia S, Sangwan VS.

Indian J Ophthalmol. 2015 Mar;63(3):233-8. doi: 10.4103/0301-4738.156927.

5.

[Aortic regurgitation with osteogenesis imperfecta].

Miyasaka S, Morimoto K, Nishimura K, Fujiwara Y.

Kyobu Geka. 2015 May;68(5):353-6. Japanese.

PMID:
25963783
6.

Whole-exome sequencing identifies de novo mutation in the COL1A1 gene to underlie the severe osteogenesis imperfecta.

Maasalu K, Nikopensius T, Kõks S, Nõukas M, Kals M, Prans E, Zhytnik L, Metspalu A, Märtson A.

Hum Genomics. 2015 May 10;9:6. doi: 10.1186/s40246-015-0028-0.

7.

Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta.

Lindahl K, Åström E, Rubin CJ, Grigelioniene G, Malmgren B, Ljunggren Ö, Kindmark A.

Eur J Hum Genet. 2015 Aug;23(8):1042-50. doi: 10.1038/ejhg.2015.81. Epub 2015 May 6.

PMID:
25944380
8.

Identify the signature genes for diagnose of uveal melanoma by weight gene co-expression network analysis.

Shi K, Bing ZT, Cao GQ, Guo L, Cao YN, Jiang HO, Zhang MX.

Int J Ophthalmol. 2015 Apr 18;8(2):269-74. doi: 10.3980/j.issn.2222-3959.2015.02.10. eCollection 2015.

9.

Osteoporosis: Clinical Evaluation.

Lewiecki EM.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Feb 28.

10.

Sodium fluorescein use during intraoperative cystoscopy.

Doyle PJ, Lipetskaia L, Duecy E, Buchsbaum G, Wood RW.

Obstet Gynecol. 2015 Mar;125(3):548-50. doi: 10.1097/AOG.0000000000000675.

PMID:
25730214
11.

A Novel Mgp-Cre Knock-In Mouse Reveals an Anticalcification/Antistiffness Candidate Gene in the Trabecular Meshwork and Peripapillary Scleral Region.

Borrás T, Smith MH, Buie LK.

Invest Ophthalmol Vis Sci. 2015 Apr 1;56(4):2203-14. doi: 10.1167/iovs.15-16460.

PMID:
25711639
12.

Osteogenesis imperfecta Type I caused by a novel mutation in the start codon of the COL1A1 gene in a Korean family.

Cho SY, Lee JH, Ki CS, Chang MS, Jin DK, Han HS.

Ann Clin Lab Sci. 2015 Winter;45(1):100-5.

PMID:
25696019
13.

Heterozygous mutation of c.3521C>T in COL1A1 may cause mild osteogenesis imperfecta/Ehlers-Danlos syndrome in a Chinese family.

Shi X, Lu Y, Wang Y, Zhang YA, Teng Y, Han W, Han Z, Li T, Chen M, Liu J, Fang F, Dou C, Ren X, Han J.

Intractable Rare Dis Res. 2015 Feb;4(1):49-53. doi: 10.5582/irdr.2014.01039.

14.

New antiepileptic medication linked to blue discoloration of the skin and eyes.

Clark S, Antell A, Kaufman K.

Ther Adv Drug Saf. 2015 Feb;6(1):15-9. doi: 10.1177/2042098614560736. Review.

15.

Cosmetic preservatives as therapeutic corneal and scleral tissue cross-linking agents.

Babar N, Kim M, Cao K, Shimizu Y, Kim SY, Takaoka A, Trokel SL, Paik DC.

Invest Ophthalmol Vis Sci. 2015 Jan 29;56(2):1274-82. doi: 10.1167/iovs.14-16035.

PMID:
25634979
16.

Dose-dependent collagen cross-linking of rabbit scleral tissue by blue light and riboflavin treatment probed by dynamic shear rheology.

Schuldt C, Karl A, Körber N, Koch C, Liu Q, Fritsch AW, Reichenbach A, Wiedemann P, Käs JA, Francke M, Iseli HP.

Acta Ophthalmol. 2015 Aug;93(5):e328-36. doi: 10.1111/aos.12621. Epub 2014 Dec 16.

PMID:
25516112
17.

Osteogenesis imperfecta and primary open angle glaucoma: genotypic analysis of a new phenotypic association.

Wallace DJ, Chau FY, Santiago-Turla C, Hauser M, Challa P, Lee PP, Herndon LW, Allingham RR.

Mol Vis. 2014 Aug 29;20:1174-81. eCollection 2014.

18.

Retinal biocompatibility of brilliant blue g with deuterated water for chromovitrectomy.

Badaró E, Moraes-Filho M, Maia M, Penha FM, Novais EA, Souza-Lima RA, Hirai F, Meyer CH, Farah ME, Rodrigues EB.

J Ophthalmic Vis Res. 2014 Apr;9(2):204-9.

19.

Two years' experience with denosumab for children with osteogenesis imperfecta type VI.

Hoyer-Kuhn H, Netzer C, Koerber F, Schoenau E, Semler O.

Orphanet J Rare Dis. 2014 Sep 26;9:145. doi: 10.1186/s13023-014-0145-1.

20.

Osteogenesis imperfecta--multi-systemic and life-long disease that affects whole family.

Primorac D, Anticević D, Barisić I, Hudetz D, Ivković A.

Coll Antropol. 2014 Jun;38(2):767-72. Review.

PMID:
25145021
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk